Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06587191 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis

Study acronym: CGM EMA
StatusUnknown
PhaseNot specified
Started2024-08-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-06
minor
Trial status changed: Active, Not Recruiting → Unknown
2024-09-30
minor
Study Status v1
Trial statusActive, Not Recruiting→Unknown
2024-09-05
minor
Original filing
The goal of this retrospective study is to assess efficacy and safety of emapalumab prescribed for the treatment in children with refractory from of pHLH.
Trial Details
NCT Number NCT06587191
Lead Sponsor Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Conditions Primary Hemophagocytic Lymphohistiocytosis
Enrollment 7 participants
Start Date 2024-08-01
Primary Completion 2024-09-01 (estimated)
Study Completion 2024-10-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-01